More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study

BACKGROUND: The clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor (DPP4i)-associated bullous pemphigoid (BP) is inconsistent in the current literature. OBJECTIVES: The aims were to investigate the clinical and immunological features of patients with DPP4i-associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Ständer, Sascha, Schmidt, Enno, Zillikens, Detlef, Ludwig, Ralf J., Kridin, Khalaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847447/
https://www.ncbi.nlm.nih.gov/pubmed/33026629
http://dx.doi.org/10.1007/s40257-020-00563-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847447/
https://www.ncbi.nlm.nih.gov/pubmed/33026629
http://dx.doi.org/10.1007/s40257-020-00563-7

Ejemplares similares